In hospital cardiac arrest in Intensive Care Unit versus non Intensive Care Unit patients with COVID 19. A systematic review and meta analysis
Mavrovounis, G.; Mermiri, M.; Chalkias, A.; Sheth, V.; Tsolaki, V.; Gourgoulianis, K.; Pantazopoulos, I.
Show abstract
AimTo estimate the incidence of in-hospital cardiac arrest (IHCA) and return of spontaneous circulation (ROSC) in COVID-19 patients, as well as to compare the incidence and outcomes of IHCA in Intensive Care Unit (ICU) versus non-ICU patients with COVID-19. MethodsWe systematically reviewed the PubMed, Scopus and clinicaltrials.gov databases to identify relevant studies. ResultsEleven studies were included in our study. The pooled prevalence/incidence, pooled odds ratios (OR) and 95% Confidence Intervals (95% CI) were calculated, as appropriate. The quality of the included studies was assessed using appropriate tools. The pooled incidence of IHCA in COVID-19 patients was 7% [95% CI: 4 - 11%; P < 0.0001] and 44% [95% CI: 30 - 58%; P < 0.0001] achieved ROSC. Of those that survived, 58% [95% CI: 42 - 74%; P < 0.0001] had a good neurological outcome (Cerebral Performance Category 1 or 2) and the mortality at the last follow-up was 59% [95% CI: 37 - 81%; P < 0.0001]. A statistically significant higher percentage of ROSC [OR (95% CI): 5.088 (2.852, 9.079); P < 0.0001] was found among ICU patients versus those in the general wards. ConclusionThe incidence of IHCA amongst hospitalized COVID-19 patients is 7%, with 44% of them achieving ROSC. Patients in the ICU were more likely to achieve ROSC than those in the general wards, however the mortality did not differ. What this paper addsSection 1: What is already known on this subject O_LIMortality in COVID-19 patients ranges between 20% and 40%. C_LIO_LIit has been reported that patients with COVID-19 have a high incidence of IHCA and higher mortality. C_LIO_LIThis paper aimed to calculate the proportion of COVID-19 patients who experience IHCA and their outcome, as well as compare the outcome of IHCA between ICU and non-ICU patients. C_LI Section 2: What this study adds O_LIApproximately 7% of hospitalized COVID-19 patients suffer from IHCA and 44% of those achieve ROSC. C_LIO_LIThe rate of ROSC was higher in ICU patients, but the rate of mortality did not differe between ICU and non-ICU patients. C_LI
Matching journals
The top 2 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Can we predict the severe course of COVID-19 – a systematic review and meta-analysis of indicators of clinical outcome? 96%
- Predictors of successful weaning from Veno-Arterial Extracorporeal Membrane Oxygenation (V-A ECMO): A Systematic Review and Meta-analysis 96%
- Population risk factors for severe disease and mortality in COVID-19: A global systematic review and meta-analysis 95%
Similar papers in this journal
- Diversity of CPR manikins for basic life support education: Use of manikin sex, race, and body shape – A scoping review 93%
- Evaluating the impact of a pulse oximetry remote monitoring programme on mortality and healthcare utilisation in patients with covid-19 assessed in Accident and Emergency departments in England: a retrospective matched cohort study 91%
- Accuracy of the National Early Warning Score version 2 (NEWS2) in predicting need for time-critical treatment: Retrospective observational cohort study 91%
Similar papers in this journal
- Performance of digital Early Warning Score (NEWS2) in a cardiac specialist setting: retrospective cohort study 94%
- Face-to-face interventions to encourage enrolment in cardiac rehabilitation; a scoping review protocol 94%
- Use of the first National Early Warning Score recorded within 24 hours of admission to estimate the risk of in-hospital mortality in unplanned COVID-19 patients: a retrospective cohort study 94%
Similar papers in this journal
- Association of the medical therapy with beta-blockers or inhibitors of renin-angiotensin system with clinical outcomes in patients with mildly reduced left ventricular ejection fraction after acute myocardial infarction 93%
- Combination therapy of Tocilizumab and steroid for management of COVID-19 associated cytokine release syndrome: A single center experience from Pune, Western India 92%
- Decreased door-to-balloon time in patients with ST-segment elevation myocardial infarction during the early COVID-19 pandemic in South Korea – an observational study 92%
Similar papers in this journal
- Nosocomial Infections Among Patients with COVID-19, SARS and MERS: A Rapid Review and Meta-Analysis 91%
- Chest Computed Tomography for the Diagnosis of Patients with Coronavirus Disease 2019 (COVID-19): A Rapid Review and Meta-Analysis 90%
- A Novel Triage Tool of Artificial Intelligence-Assisted Diagnosis Aid System for Suspected COVID-19 Pneumonia in Fever Clinics 90%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.